Bristol-Myers Squibb (NYSE:BMY) recently reported its Q1 earnings, and they came in slightly above our estimates, led by margin expansion. This note details the company’s Q1 performance, and Trefis’ forecasts for the full year 2019. You can view our interactive dashboard analysis ~ How Did Bristol..
